Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
Karuna Kumar, Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn about a recent article by Mamadou Bah published in The American Journal of Clinical Nutrition, adding:
“Interesting trial from Gambia on treating iron deficiency in children.
The problem:
- Ferrous sulfate tablets work poorly in kids with chronic inflammation.
- Poor absorption.
- GI upset.
- Low compliance.
This study tested heme iron polypeptide (HIP) against standard ferrous salts.
Heme iron is the form found in meat.
It absorbs through a different pathway than regular iron supplements.
Doesn’t get blocked by inflammation the same way.
The results?
Both raised hemoglobin. But heme iron had better tolerability and absorption in kids with high inflammation markers.
Why this matters for India:
We have millions of children with chronic infections, parasites, and subclinical inflammation.
Standard iron tablets often fail them.
Heme iron supplements exist but are underused. They cost more, yes. But if regular iron isn’t working after 2-3 months, it’s worth considering.
Not every anemia responds to the cheapest option. Sometimes you need to match the treatment to the patient.”
Title: Heme iron compared with ferrous iron salts to treat iron deficiency anemia in Gambian children: a randomized controlled trial
Authors: Mamadou Bah, Hans Verhoef, Emmanuel Okoh, Abdoulie Bah, Alhasan Colley, Alasana Saidykhan, Andrew M Prentice, Carla Cerami
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 04:15Wolfgang Miesbach: First AAV Gene Therapy Data in Adolescents With Haemophilia B
-
Sep 22, 2026, 04:03Emmanuel J Favaloro: 100 Years of VWD – A Special Virtual Issue
-
Sep 22, 2026, 03:31Mostafa Elshazly: How Is Humidification Used During Non Invasive Ventilation?
-
Sep 22, 2026, 03:05Sumyea Kabir: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 02:33Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders